Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Intervalo de año de publicación
1.
Tissue Antigens ; 82(6): 397-404, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24498996

RESUMEN

Killer cell immunoglobulin-like receptors (KIR) form a group of regulatory molecules that specifically recognise human leukocyte antigen (HLA) class I molecules, modulating the cytolytic activity of natural killer cells. The purpose of this study was to investigate the influence of KIR genes and their class I HLA ligands in susceptibility to dengue fever in a population from southern Brazil through a case-control study. One hundred four subjects with confirmed diagnoses of dengue participated in this study, along with a control group of 172 individuals from the same geographic area. HLA and KIR genotyping was performed by polymerase chain reaction with sequence-specific oligonucleotide probes (PCR-SSOP) and with sequence-specific primer (PCR-SSP) techniques, respectively. Data analysis showed significant differences for the KIR2DS1 (54.8% vs 40.7%, P = 0.03), KIR2DS5 (50.0% vs 36.0%, P = 0.03) and KIR2DL5 (76.0% vs 56.4%, P = 0.001) genes. With regard to KIR-ligand pairs, positive associations with dengue were observed in KIR3DS1-Bw4 (45.2% vs 29.7%, P = 0.01), KIR3DL1-Bw4 (80.7% vs 65.1%, P < 0.001), KIR2DL1-C2 (75.0% vs 62.2%, P = 0.03) and KIR2DS1-C2 (40.4% vs 25.6%, P = 0.01) interactions, and a negative association in KIR2DL3-C1/C1 (18.2% vs 33.1%, P = 0.01). Furthermore, the analysis of KIR haplogroups showed a possible protective factor against dengue fever in individuals with the AA genotype. Taken together, these results suggest the existence of genetic predisposition to dengue fever in the population from southern Brazil.


Asunto(s)
Dengue/inmunología , Antígenos HLA/genética , Receptores KIR/genética , Adolescente , Adulto , Brasil , Estudios de Casos y Controles , Dengue/genética , Femenino , Frecuencia de los Genes , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Genotipo , Prueba de Histocompatibilidad , Humanos , Masculino , Polimorfismo Genético , Unión Proteica , Adulto Joven
2.
Scand J Immunol ; 76(4): 440-7, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22803655

RESUMEN

The objective of this study was to investigate human leucocyte antigen (HLA) genes in patients chronically infected with hepatitis C virus (HCV) and to analyse the possible role of these genes in the progression of chronic hepatitis C. One hundred and forty-five (145) Brazilian patients infected only with HCV genotype 1 were evaluated. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1) typing were carried out by PCR-SSO, through Luminex technology. Associations were found with protection against development of liver damage by both DRB1 11 (5.0% versus 18.2%, P=0.0016, OR=0.23, CI 95% = 0.09-0.58; Pc=0.0208) and DRB1 11-DQA1 05-DQB1 03 haplotype (4.2% versus 15.3%, P=0.0032; OR = 0.24, CI 95% = 0.08-0.64). Liver damage was associated with HLA-C 04 in patients with <20 years of infection (38.4% versus 9.1%, P = 0.002, OR = 6.25, CI 95%=1.97-19.7; Pc=0.0238). It is concluded that HLA alleles can influence the development of liver damage in HCV type-1 chronically infected Brazilian patients.


Asunto(s)
Antígenos HLA-C/genética , Cadenas HLA-DRB1/genética , Hepatitis C Crónica/inmunología , Cirrosis Hepática/inmunología , Hígado/inmunología , Adulto , Alelos , Brasil , Femenino , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Antígenos HLA-C/inmunología , Cadenas HLA-DRB1/inmunología , Haplotipos , Hepatitis C Crónica/complicaciones , Hepatitis C Crónica/patología , Hepatitis C Crónica/virología , Humanos , Inmunofenotipificación , Hígado/patología , Hígado/virología , Cirrosis Hepática/etiología , Cirrosis Hepática/patología , Cirrosis Hepática/virología , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Factores de Tiempo
3.
Int J Immunogenet ; 39(4): 296-302, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22284614

RESUMEN

The objective of this study was to analyse the possible role of HLA polymorphism of chronically infected hepatitis C virus patients in the response outcome to treatment with pegylated interferon-alpha plus ribavirin. To that end, 144 Brazilian patients infected only with genotype 1 of the virus were treated with pegylated interferon-alpha at 1.5 µg kg(-1) in conjunction with ribavirin (1000 mg if patient weight was <75 kg and 1250 mg if >75 kg) for 48 weeks. The patients did not have concomitant HBV or HIV infections or liver disease, did not undergo previous antiviral treatment, and were followed up for 24 weeks after the end of treatment to assure they presented a sustained virological response. Patients were classified according to response to treatment in responsive (SVR), nonresponsive (NRS) and relapsers (REL). HLA class I and class II typing were carried out through PCR-SSO using Luminex technology. A statistically higher frequency of DRB1*11 patients was observed in the SVR group (39.6% vs. 14.3%P = 0.0012; Pc = 0.0156; OR = 3.94; 95% CI = 1.8-8.8). HLA-DQB1*03 patients were also more frequent in the SVR group, but the P value lost significance after Bonferroni correction (62.3% vs. 41.7%P = 0.024; Pc = 0.14, OR = 2.3; 95% CI = 1.14-4.60). HLA class II antigens can positively influence the response to treatment with pegylated interferon-alpha and ribavirin.


Asunto(s)
Alelos , Genes MHC Clase II , Genes MHC Clase I , Hepatitis C Crónica/genética , Interferón-alfa/uso terapéutico , Ribavirina/uso terapéutico , Adulto , Quimioterapia Combinada/métodos , Femenino , Estudios de Seguimiento , Genotipo , Cadenas HLA-DRB1/genética , Hepacivirus/genética , Hepatitis C Crónica/tratamiento farmacológico , Prueba de Histocompatibilidad/métodos , Humanos , Interferón-alfa/administración & dosificación , Masculino , Persona de Mediana Edad , ARN Viral/sangre , Recurrencia , Ribavirina/administración & dosificación , Resultado del Tratamiento
4.
Rev. ciênc. farm. básica apl ; Rev. ciênc. farm. básica apl;30(2)2009.
Artículo en Portugués | LILACS | ID: lil-535415

RESUMEN

The aim of this study was to investigate the diversity and prevalence of yeasts, and the virulence of C.albicans found in the oral cavity during the course of ionizing radiation treatment of patients with head and neck tumor (HNTP). Samples from 21 HNTP and 24 healthy controls were isolated and identified. C. albicans isolated from two patients during radiotherapy were analyzed for virulence factors. Radiotherapy induced a higher level of both yeast colonization (81% vs 33%) and non-albicans Candida (NAC) colonization (52.4% vs 4.0%) in HNTP than the control group. Patients were colonized by 5 different NAC species: C. glabrata, C. tropicalis, C. parapsilosis, C. krusei and C. kefir. On the other hand, C. albicans colonization was similar in patients and controls (6/21, 28.6% vs 7/24, 29.2%, respectively). Also, of the 11 patients assessed before and during radiotherapy, 5 (45.5%) were colonized before the start of treatment and another 5 (45.5%) during treatment. All of the latter were colonized by NAC species alone. Moreover, we observed a significant and continuous enhancement of C. albicans virulence as the radiotherapy progressed, in the two patients involved in this test. Thus, it is concluded that radiotherapy is an important predisposing factor for the oral candidiasis, including NAC species. Also, it may facilitate the development of more virulent C. albicans strains.


O objetivo deste estudo foi avaliar a diversidade e a prevalência de Cândida, bem como a virulência de Cândida albicans, isoladas da cavidade bucal no decurso de tratamento por radiações ionizantes de pacientes acometidos por tumores de cabeça e pescoço (PTCP). Amostras de 21 pacientes e 24 controles foram analisadas. C. albicans isoladas de dois pacientes ao longo do tratamento radioterápico foram avaliadas para fatores de virulência. A radioterapia induziu um grande aumento da colonização de Cândida como um todo (81% vs 33%) e Cândida não albicans (CNA) em particular (52.4% vs 4.0%) em PTCP quando comparado com controles não irradiados. Cinco espécies diferentes de CNA foram encontradas nos pacientes: C. glabrata, C. tropicalis, C. parapsilosis, C. krusei and C. kefir. Por outro lado, a colonização por C. albicans nestes pacientes e controles foi similar (6/21, 28.6% vs 7/24, 29.2%, respectivamente). Além disso, dos 11 pacientes que foram avaliados antes e durante o tratamento radioterápico, 5 pacientes (45,5%) foram colonizados antes do início da radioterapia e outros 5 (45,5%) durante o tratamento radioterápico. Destes últimos, todos foram colonizados apenas com espécies CNA. Observou-se, ainda, um aumento contínuo e significante da virulência de C. albicans com o progresso da radioterapia nos dois pacientes estudados. Conclui-se que o tratamento radioterápico é um importante fator de desenvolvimento de candidíase oral, incluindo candidíase por espécies não albicans, em pacientes portadores de tumor de cabeça e pescoço. A radioterapia pode, ainda, facilitar o desenvolvimento de cepas mais virulentas de C.albicans.


Asunto(s)
Humanos , Masculino , Femenino , Candida albicans , Candidiasis Bucal , Boca , Neoplasias de Cabeza y Cuello/complicaciones , Radioterapia , Factores de Virulencia
5.
J Mater Sci Mater Med ; 13(12): 1175-80, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15348662

RESUMEN

In this work, poly(N-isopropylacrylamide) (PNIPAAm) was incorporated into previously oxidized PS and PET surfaces by grafting using two photo-initiation pathways. The incorporation of PNIPAAm was observed by drop water contact angle measurements, dyeing with Methylene Blue and AFM images analysis of the virgin and modified polymers. It was verified that the grafting process depends on the chemical surface environment. The grafted surfaces are hydrophilic below 32 degrees C and hydrophobic above this temperature. The transition is due to the incorporated PNIPAAm. This characteristic gives to the grafted materials potential to be applied as biomaterials.

6.
J Rheumatol ; 27(6): 1518-20, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10852281

RESUMEN

OBJECTIVE: Rheumatic fever (RF) is a multisystem inflammatory disease that develops as a sequel of untreated throat infection by the group A beta-hemolytic streptococcus. As HLA antigens are known to be important in controlling immunological responsiveness, studies have investigated HLA antigen association with RF. Studies with Caucasians, Black Americans, and Indians showed associations with HLA-DR4, DR2, and DR3, respectively. One study on a Brazilian population suggested an association with HLA-DR7 and HLA-DR53. We investigated the association between RF and antigens HLA-DR7 and DR53 in the white Brazilian population. METHODS: Thirty-five patients and 209 healthy individuals living in the northern region of the state of Parana, Brazil, were used as test and control groups, respectively. Classical statistical methods were used to compare HLA frequencies between these groups. Results. Data confirmed positive association with HLA-DR7 (46.7 vs. 25.7%; p = 0.015), but not with HLA-DR53 (54.3 vs. 44.5%; p = 0.28). The relative risk and etiologic fractions were 2.4 and 0.27%, respectively. CONCLUSION: Positive association between HLA-DR7 specificity and RF was observed in the white Brazilian population by 2 independent studies, supporting the hypothesis of the involvement of genetic factors in susceptibility of rheumatic fever.


Asunto(s)
Antígeno HLA-DR7/genética , Fiebre Reumática/genética , Fiebre Reumática/inmunología , Brasil , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Antígenos HLA-DQ/genética , Antígenos HLA-DR/genética , Cadenas HLA-DRB4 , Humanos , Población Blanca/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA